Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Klatovy – page 2

21 clinical trials in Klatovy, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Klatovy at a glance
21
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

21 trials in Klatovy

Open in trial search

Colitis ulcerative+1

Not recruiting

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Colitis ulcerative

Not recruiting

Study on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Eclitasertib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Vedolizumab
  • Sponsor:Polpharma Biologics S.A.

Colitis ulcerative

Not recruiting

Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Pain+1

Not recruiting

Comparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Chondroitin sulfate (marine)
  • Sponsor:IBSA Institut Biochimique SA

Colitis ulcerative

Not recruiting

Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Crohn's disease

Not recruiting

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Oedema

Not recruiting

Study on Reducing Peripheral Edema in Patients Switching from Amlodipine Besilate to Levamlodipine Succinate

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine Besilate
  • Sponsor:Zentiva k.s.

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Klatovy

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Comprehensive studies focusing on ulcerative colitis and Crohn's disease treatments, evaluating novel therapeutic approaches for patients with moderate to severe conditions.

  • TEV-48574 Clinical Evaluation
  • Etrasimod Safety Studies
  • Bowel Urgency Management

Multiple parallel investigations examining both short-term efficacy and long-term maintenance therapy outcomes.

02 Musculoskeletal Conditions

Investigation comparing different sources of chondroitin sulfate in treating knee osteoarthritis, examining efficacy and safety profiles of marine versus bovine origins.

  • Pain Management
  • Functional Impairment
  • Treatment Comparison Studies

Focus on improving mobility and reducing pain in patients with moderate to severe symptoms.

03 Gastrointestinal Disorders

Advanced research into celiac disease treatments, including studies of novel antibody therapies and their effectiveness in combination with dietary interventions.

  • Non-responsive Celiac Disease
  • Gluten Exposure Studies
  • Intestinal Mucosa Research

Evaluating innovative approaches for patients who don't respond to traditional treatments.

04 Cardiovascular Medicine

Clinical evaluation of treatments for peripheral edema, comparing the effectiveness of different medications in patients on long-term therapy.

  • Edema Assessment Methods
  • Treatment Tolerability
  • Patient Response Monitoring

Focus on improving patient comfort and treatment outcomes through medication optimization.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.